Clinical Trials Browser

Terminated × Everolimus × Sarcoma × Clear all

NCT01048723 2013-12-16

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

Phase 2 Terminated

2 enrolled 3 charts

Sarcoma

NCT01412515 2012-01-02

A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

Phase 2 Terminated

Sarcoma, Kaposi